Be part of the 420 best cannabis investor ideas of 2017. If you are a publicly traded company on any recognized stock exchange, a private company, a newsletter, equity research, technical trading site, or any company or service that is participating in the exploding legal marijuana market - tell investors your story.
Investorideas.com and 420cannabisinvestorideas.com are launching a campaign to feature 420 ideas for the year. We will end the campaign at 420 and create a downloadable PDF for investors with each company.
Our goal - get the list of 420 completed by 4/20
What you get
Featured on Investorideas.com, 420cannabisinvestorideas.com and Globalcannabisinvesting.com
Company profile up to 1000 character description
Logo, link to your site and 2 social media links Plus a Youtube video if you have one
Your profile will be featured on the directory page until the end of 2017
Your profile will be on the downloadable free PDF for investors for one year
Press release on the Investorideas.com Newswire announcing your company as one of the 420 ideas. Your news will be on Google news, social media and global syndication plus Globalcannabisinvesting.com. Your news will be published on social media for 2 days. ($500 value)
Up to 3 free press releases on Investorideas.com hub ($500 value each for total of $1500)
Inclusion in a press release on Investor Hub announcing your company to the directory ($100 value)
Be featured in ongoing marketing and social media campaigns for the year
What does it cost?
$1000 for the year - profile, directory and news release in one
Send us your company description, logo and info above for our directory to this email
Once we have your PayPal payment we will publish your profile and issue a press release the following day.
Aphria Inc. (TSX: APH.TO or USOTCQB: APHQF) is a Canadian company listed on the TSX Venture Exchange. The Company is located in Leamington, Ontario and is a Health Canada approved licensed producer of high quality 100% greenhouse grown medical cannabis products. Aphria produces and sells their products (currently dried bud and cannabis oil) through 2 primary channels; retail and wholesale. Retail sales are exclusively direct to consumer, a model that is mandated by Health Canada under the ACMPR ('Access to Cannabis for Medical Purposes Regulations'). Through this model, customers place orders online or by telephone and the product is shipped directly to their address. Aphria's wholesale business involves selling bulk product to other licensed producers. The company is also committed to supporting cannabis R&D through various means including strategic partnerships and the development of in house capabilities. In short, Aphria is committed to providing pharma-grade medical cannabis and superior patient care, while balancing patient economics and returns to shareholders.
Algae Dynamics Corp (OTCQB: ADYNF), a development stage company focused on the commercialization of its proprietary BioSilo(R) cultivation and extraction system for the growth of algae strains for use in the food and health supplement industry.
420 Investor has been the leading source of information on publicly-traded cannabis stock since 2013, when Alan Brochstein, CFA became the first investment professional sharing his research on the sector with individual investors. More than a newsletter, 420i is a community that invites engagement from its subscribers, who comment on posts, participate in a weekly chat and participate in the Forum. The service includes timely news alerts, 4 model portfolios and trade alerts, weekly chat, 10 videos per week, a Forum, a weekly written summary and a monthly newsletter.
Viridian Capital Advisors, LLC (www.viridianca.com) is a financial and strategic advisory firm dedicated to the cannabis market. We are a data- and market intelligence-driven firm that provides investment banking, M&A, corporate development, and investor relations services to emerging growth companies and qualified investors in the cannabis sector. Our banking practice, through broker-dealer Pickwick Capital Partners, LLC, Member FINRA/SIPC, provides capital and M&A to fund the growth of our clients, while our advisory practice helps to position and build their businesses. Our team's decades of high level operating and transactional experience on Wall Street in a variety of emerging sectors, allows Viridian to provide comprehensive strategic and financial solutions that assist cannabis enterprises in realizing their full potential.
Profile Solutions, Inc. (OTC: PSIQ) designs, develops, manufactures and sells security - based identification products and systems that incorporate state - of - the - art security technology to verify a person's identity, or grant physical access. PSI has developed turnkey integrated applications that incorporate our proprietary Access - It hardware platform: We also integrate our applications with our patented biometric technology for additional security when required. PSI targets the Cannabis Industry, Corporate America and the Consumer as our customer base.
Electrum Partners is known for its pioneering role and influence in the cannabis industry as a global cannabis business advisory and services firm with a preeminent leadership team. Leslie Bocskor, Founder of Electrum Partners, has become one of the most influential and celebrated leaders in the cannabis industry, sought after by policy makers, investors, entrepreneurs, and other leaders. The firm's mission expresses a shared vision of social justice and the opportunity to create markets and companies that innovate and serve the public. Solely focused on the cannabis industry, Electrum Partners promotes an open-source culture of mentorship and collaboration and seeks to bring best practices throughout the industry, working with highly-dedicated, teams and individuals.
Electrum Partners serves leading international and regional cannabis companies in hemp, medical marijuana and recreational marijuana (including cannabis pharmaceuticals, nutraceuticals and biotech), technology, ERP, retail sales, processing and cultivation, ecommerce, unique brands, edibles manufacturing, intellectual property, finance, banking and others. Electrum Partners maintains membership and relationships with key industry groups including The ArcView Group, the Marijuana Policy Project (MPP ), the Drug Policy Alliance (DPA), and Women Grow.
INTERPHEX Live: Medicine Authenticity: From Seed to Solution with Leaps in Cannabis Progress
Cannabis Industry 2016 Year-end Review with Leslie Bocskor, Electrum Partners | Stock News Now
Leslie Bocskor of Electrum Partners talks about the once in a lifetime opportunity in the cannabis industry
New Frontier Data is an independent, technology-driven analytics company specializing in the cannabis industry. We offer vetted data, business intelligence and risk management solutions for investors, operators, and policymakers. New Frontier's data and reports have been cited in over 45 countries around the world to inform industry leaders. Founded in 2014, New Frontier is headquartered in Washington, D.C. and has an additional office in Denver, Colorado. For more information or sales inquiries, please visit www.newfrontierdata.com or contact James Ford at 703-843-6613 or firstname.lastname@example.org
Founded in 2010, The Arcview Group is responsible for a number of groundbreaking ventures in the cannabis industry. Arcview Market Research is the first and most oft-cited publisher of market research on the cannabis industry. The Arcview Investor Network includes 625+ dues-paying accredited investors who have put more than $107 million behind 140 companies. Arcview is a partner in Canopy, a seed-stage mentor-driven business accelerator. Arcview is also co-founder of Cannasure Insurance Services, the leading provider of business insurance to the cannabis industry.
SinglePoint, Inc. (OTC: SING) has grown from a full-service mobile technology provider to a publicly traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base. Through its subsidiary company SingleSeed the company is providing products and services to the cannabis industry. www.SinglePoint.com
March 14, 2017 / SinglePoint, Inc. (OTC: SING) a holding company specialized in the acquisition of small to mid-sized companies, announces that it has closed its first round of funding to acquire a portion of Jacksam Corp., dba Convectium, the developer of a unique oil filling system poised to revolutionize the cannabis market. Convectium projects full-year 2017 sales of $3.5 million, a triple-digit increase over the year prior. The acquisition represents the first of many strategic investments SinglePoint intends to make to diversify its revenue streams in the multi-billion dollar cannabis industry. Full news: http://ir.singlepoint.com/press-releases/detail/96/singlepoint-inc-acquires-stake-in-convectium-deepens
American Growth Fund Series Two (NASDAQ: AMREX) is currently the country's only Cannabis Mutual Fund. Headquartered in Denver, this diversified fund, focuses solely on the cannabis industry. Approved by the SEC, it invests in publicly traded companies in areas that support this exploding industry like pharmaceuticals, agriculture, hydroponic, equipment, to name a few.
Healthtalk Live Inc., a Santa Monica California based consumer and media company specializing in brand development of health conscious, hemp-infused food and beverage products.
Humbly Hemp is a product line of delicious hemp based products. The snack line will feature hemp and CBD based foods that will delight the palette of consumers and thrill retailers with America's fastest growing food category. A new CBD hemp based water line will be soon introduced sourced from an exclusive spring that is high in alkalinity and pure as the driven snow from where it came.
Scythian Biosciences Corp. (TSX.V: SCYB) is a pre-clinical research and development company that is in the process of developing drug therapies. The first project underway is the development of a proprietary cannabinoid-based combination drug therapy for the treatment of concussions and traumatic brain injury. In addition to this primary line of research and development, Scythian also intends to develop other potential cannabinoid and non-cannabinoid based pharmaceutical products, including one that is in development for treatment of gastro-inflammatory disease.